SAN FRANCISCO, CA--(Marketwired - June 27, 2016) - Medivation, Inc. (MDVN) today announced that it has been named one of the San Francisco Bay Area's Top Workplaces for the fourth year in a row. Medivation was ranked among large companies, which includes companies with more than 500 employees. The Top Workplaces are determined based solely on employee feedback as reported in an annual employee survey which highlights key strengths of the company both in the health of the organization (alignment, execution and connection) and in personal job satisfaction (work, manager, pay and benefits).
"Being named a Bay Area Top Workplace for four consecutive years is a testament to the passionate team we have at Medivation," said Sandy Cooper, senior vice president of human resources at Medivation. "This award highlights the high standards to which our team holds itself and represents our dedication to constantly improving to achieve our goals."
"This recognition comes at an exciting time for the Company -- our first commercialized product has achieved blockbuster status, we have an exciting pipeline of wholly owned late-stage assets, and we are scaling the organization to support our continued growth," said David Hung, M.D., founder, president and chief executive officer at Medivation. "All of these accomplishments are the result of the tireless efforts of our amazing team which, at every level of the Company, is committed to our mission of urgently developing innovative treatments for patients with serious unmet medical needs."
The Top Workplaces distinction is sponsored by the San Francisco Bay Area News Group. Full results of the annual employee survey are being featured in the Top Workplaces special edition in all of the Bay Area News Group's publications, including in the San Jose Mercury News, which appeared on June 26, 2016.
About Medivation Inc.
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit http://www.medivation.com.